Shantanu Nigam
Managing Partner @ SeedToB Capital
Atlanta, United States
Shantanu Nigam is a seed investor at SeedToB Capital in Atlanta focused on Health Care and Health Diagnostics. Shantanu is a veteran entrepreneur with a passion for Artificial Intelligence and patient wellness. In the late 90s, Shantanu founded an Artificial Intelligence company with the goal of shifting search algorithms from keyword-based to Eigen Space-based and intent driven.For the most part of 2000s, Shantanu served as a leader in Accenture'sHealthcare practice and helped drive the firm's healthcare solutions and innovation projects. In his current role, Shantanu leads predictive leader Jvion where he and his team have worked to combine Artificial Intelligence and patient wellness to deliver a predictive solution that prevents patient suffering. Shantanu earned his Bachelor of Engineering from the Indian Institute of Technology in India.
- Total investments:
- 8
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Shantanu Nigam invests in
Stages Shantanu Nigam invests in
Countries Shantanu Nigam invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 3 (38%)
- Health Diagnostics 2 (25%)
- Events 1 (13%)
- Medical 1 (13%)
- Oncology 1 (13%)
Stage
- Seed 2 (25%)
- Pre-Seed 2 (25%)
- Series A 1 (13%)
- Series B 1 (13%)
- Funding Round 1 (13%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| AI collaborators for all patient interactions, including fax, email, text, and voice | Pre-Seed / Jun 03, 2025 | ||
| OncoLens develops technologies that improve cancer treatment planning, simplify tumor board management, facilitate survivorship care planning, and automate accreditation and quality reporting through an intelligent workflow engine that streamlines business processes and enables more informed clinical decision-making. | $16M / Series B / Oct 24, 2024 | ||
| eMedEvents is an online database that provides its users with conference data mining and analytics solutions. | Venture - Series Unknown / Jul 26, 2023 | ||
| Feel Therapeutics is a digital precision medicine company delivering objective data and passive measurement for mental health. The company develops physiological and digital biomarkers and therapeutics for mental health. Its Feel data monitoring device leverages five embedded sensors via the wristband. Feel collects biometric data and analyzes themusing the latest cutting-edge methods of computer science to develop digital biomarkers.Feel Therapeutics, formerly known as Sentio Solutions. | May 19, 2022 | ||
| GritWell is redesigning chronic care, shifting focus from symptom management to root cause treatment. We help those struggling with chronic symptoms (i.e. insomnia, migraines, digestive issues, anxiety, and joint pain) or diagnosed conditions with a more holistic, root cause approach. Utilizing clinically validated symptom assessments topersonalize care for patients, we recommend them to the right level of care that targets their entire set of symptoms. | $2.5M / Seed / Feb 03, 2022 | ||
| Epinoma is a diagnostics company that focuses on the multi-omics approach to cancer monitoring. It engineers proteins that control the operating system of biology. The company was founded in 2020 and is headquartered in San Francisco, California. | Pre-Seed / Oct 21, 2021 | ||
| Epinoma is a diagnostics company that focuses on the multi-omics approach to cancer monitoring. It engineers proteins that control the operating system of biology. The company was founded in 2020 and is headquartered in San Francisco, California. | Seed / Jun 26, 2021 | ||
| OncoLens develops technologies that improve cancer treatment planning, simplify tumor board management, facilitate survivorship care planning, and automate accreditation and quality reporting through an intelligent workflow engine that streamlines business processes and enables more informed clinical decision-making. | $7.3M / Series A / Jan 14, 2021 |
Co-Investors
About SeedToB Capital
SeedToB Capital primarily focuses on artificial intelligence initiatives within healthcare. Most applications of AI in healthcare have results in pilot and early adaptor settings but don’t maximize their full potential of value despite huge investments. seedToB’s unique approach is to help entrepreneurs navigate this complex space towards mostefficient path to Series B. It is led by serial entrepreneurs who in their last startup founded Jvion and grew it to be the Nation’s largest clinical AI company which was sold at nine figure valuation in a all cash transaction.
SeedToB Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Shantanu Nigam
Managing Partner
|
|||
Ritesh Sharma
Managing Partner
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Shantanu Nigam invest in?
Shantanu Nigam invests primarily in Health Care, Health Diagnostics and Events startups, most often at Seed and Pre-Seed stage. Most of the 8 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Shantanu Nigam?
Public channels for Shantanu Nigam include LinkedIn and X (Twitter). For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Shantanu Nigam last invest?
The most recent investment recorded for Shantanu Nigam closed in Jun 2025. Shizune tracks 8 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
